Product
Help
Pricing
About
Jobs
Log in
Get started
Keyword
Add to collection
dose-ranging
Description:
A clinical research approach that compares multiple doses of a treatment to characterize dose-response relationships and inform dose selection.
OpenAlex ID:
keywords/dose-ranging-study
Human Anti–Tumor Necrosis Factor Monoclonal Antibody (Adalimumab) in Crohn’s Disease: the CLASSIC-I Trial
2006
·
Stephen B. Hanauer
, William J. Sandborn
, et al.
·
Gastroenterology
·
1,736
Ipilimumab monotherapy in patients with pretreated advanced melanoma: a randomised, double-blind, multicentre, phase 2, dose-ranging study
2009
·
Jedd D Wolchok
, Bart Neyns
, et al.
·
The Lancet Oncology
·
1,213
The efficacy and safety of rituximab in patients with active rheumatoid arthritis despite methotrexate treatment: Results of a phase IIB randomized, double‐blind, placebo‐controlled, dose‐ranging trial
2006
·
Paul Emery
, Roy Fleischmann
, et al.
·
Arthritis & Rheumatism
·
1,068
Recombinant Activated Factor VII for Acute Intracerebral Hemorrhage
2007
·
Stephan A. Mayer
·
Stroke
·
1,030
Baloxavir Marboxil for Uncomplicated Influenza in Adults and Adolescents
2018
·
Frederick G. Hayden
, Norio Sugaya
, et al.
·
New England Journal of Medicine
·
964
PDF
Brodalumab, an Anti–Interleukin-17–Receptor Antibody for Psoriasis
2012
·
Kim A. Papp
, Craig Leonardi
, et al.
·
New England Journal of Medicine
·
950
Dupilumab efficacy and safety in adults with uncontrolled persistent asthma despite use of medium-to-high-dose inhaled corticosteroids plus a long-acting β2 agonist: a randomised double-blind placebo-controlled pivotal phase 2b dose-ranging trial
2016
·
Sally Wenzel
, Mario Castro
, et al.
·
The Lancet
·
923
Effect of Anti-IgE Therapy in Patients with Peanut Allergy
2003
·
Donald Y.M. Leung
, Hugh A. Sampson
, et al.
·
New England Journal of Medicine
·
698
PDF
Adverse Upper Gastrointestinal Effects of Rofecoxib Compared With NSAIDs
1999
·
Michael J. Langman
, D M Jensen
, et al.
·
JAMA
·
678
Effects of Tolvaptan, a Vasopressin Antagonist, in Patients Hospitalized With Worsening Heart Failure A Randomized Controlled Trial
2004
·
Mihai Gheorghiade
, Wendy A Gattis
, et al.
·
JAMA
·
651
A Phase II Randomized Double-Masked Trial of Pegaptanib, an Anti–Vascular Endothelial Growth Factor Aptamer, for Diabetic Macular Edema
2005
·
Emmett T Cunningham
, Anthony P Adamis
, et al.
·
Ophthalmology
·
602
Efficacy and safety of dupilumab in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical treatments: a randomised, placebo-controlled, dose-ranging phase 2b trial
2015
·
Diamant Thaçi
, Eric L Simpson
, et al.
·
The Lancet
·
582
Safety and efficacy of the HIV-1 integrase inhibitor raltegravir (MK-0518) in treatment-experienced patients with multidrug-resistant virus: a phase II randomised controlled trial
2007
·
Beatriz Grinsztejn
, Bach-Yen Nguyen
, et al.
·
The Lancet
·
581
Antisense Inhibition of Apolipoprotein C-III in Patients with Hypertriglyceridemia
2015
·
Daniel Gaudet
, Veronica J. Alexander
, et al.
·
New England Journal of Medicine
·
541
PDF
Low-Density Lipoprotein Cholesterol–Lowering Effects of AMG 145, a Monoclonal Antibody to Proprotein Convertase Subtilisin/Kexin Type 9 Serine Protease in Patients With Heterozygous Familial Hypercholesterolemia: The Reduction of LDL-C With PCSK9 Inhibition in Heterozygous Familial Hypercholesterolemia Disorder (RUTHERFORD) Randomized Trial
2012
·
Frederick Raal
, Rob Scott
, et al.
·
Circulation
·
508
Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis
2016
·
Yongjun Wang
, Claire E Parker
, et al.
·
Cochrane Database of Systematic Reviews
·
505
PDF
Ambrisentan Therapy for Pulmonary Arterial Hypertension
2005
·
Nazzareno Galié
, David Badesch
, et al.
·
Journal of the American College of Cardiology
·
498
Benralizumab, an anti-interleukin 5 receptor α monoclonal antibody, versus placebo for uncontrolled eosinophilic asthma: a phase 2b randomised dose-ranging study
2014
·
Mario Castro
, Sally E Wenzel
, et al.
·
The Lancet Respiratory Medicine
·
497
Repeated subcutaneous injections of IL12/23 p40 neutralising antibody, ustekinumab, in patients with relapsing-remitting multiple sclerosis: a phase II, double-blind, placebo-controlled, randomised, dose-ranging study
2008
·
Benjamin M Segal
, Cris S Constantinescu
, et al.
·
The Lancet Neurology
·
495
Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis
2016
·
Yongjun Wang
, Claire E Parker
, et al.
·
Cochrane Database of Systematic Reviews
·
492
PDF
Randomized controlled trial of an oral CGRP receptor antagonist, MK-0974, in acute treatment of migraine
2007
·
T. W. Ho
, L. K. Mannix
, et al.
·
Neurology
·
466
Comparison of Methods for Analysis of Clinical [ 11 C]Raclopride Studies
1996
·
A. A. Lammertsma
, C. J. Bench
, et al.
·
Journal of Cerebral Blood Flow & Metabolism
·
463
Effect of a Monoclonal Antibody to PCSK9 on Low-Density Lipoprotein Cholesterol Levels in Statin-Intolerant Patients: The GAUSS Randomized Trial
2012
·
David Sullivan
, Anders G. Olsson
, et al.
·
JAMA
·
450
Efficacy, safety, and tolerability of a monoclonal antibody to proprotein convertase subtilisin/kexin type 9 in combination with a statin in patients with hypercholesterolaemia (LAPLACE-TIMI 57): a randomised, placebo-controlled, dose-ranging, phase 2 study
2012
·
Robert P Giugliano
, Nihar R Desai
, et al.
·
The Lancet
·
434
Dose-Ranging Effects of Canagliflozin, a Sodium-Glucose Cotransporter 2 Inhibitor, as Add-On to Metformin in Subjects With Type 2 Diabetes
2012
·
Julio Rosenstock
, Naresh Aggarwal
, et al.
·
Diabetes Care
·
432
Show more works
View as search
Works count:
2,198
Citation count:
94,750
Year
Topic
Type